• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

OneSource Specialty Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 89433.0
  • ISIN : INE013P01021
1,855.40 -119 (-6.01%)
  • As on 02 Aug 2025 (EOD)
  • Today’s Low

    1,832.00
  • Today’s High

    1,964.30
  • Open

    1,960.00
  • Perv Close

    1,974.00
  • 52W Low

    1,209.95
  • 52W High

    2,248.00

Key Indicators

  • P/E(TTM)

    159.98

  • Mar.Cap (₹Cr.)

    21,238.03

  • Div & Yield %

    0.00

  • Book Value(₹)

    517.19

  • Debt-Equity Ratio

    -6.01

  • AGM Date

    01-Aug-2025

  • EPS

    11.55

  • P/E Ratio

    159.98

Financials Ratios

  • Debt-Equity Ratio

    1.22

  • Mar.Cap (₹Cr.)

    21,238.03

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    11.45

  • BV (₹)

    517.20

  • Sales( ₹ in Cr.)

    1,299.59

  • NP (in Cr.)

    132.25

  • NP Var(%)

    149.0

  • Div%

    0.0

  • CPS (₹)

    23.30

  • EPS (₹)

    11.60

  • Traded Value (₹ in Lakhs)

    21,151.03

  • 52 Week High

    2,248.00

  • 52 Week Low

    1,209.95

  • Price BSE

    1848.0

  • Price NSE

    1,855.00

  • Market Capital( in Cr.)

    21,151.03

  • P/C Ratio

    79.30

  • P/E Ratio

    159.90

  • Price Vs.BV

    11.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 171.92 38.71 132.13 21.39 1.54 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 171.92 38.71 132.13 21.39 1.54 -
Other Income 4.23 2.70 5.86 1.01 0.76 -
Stock Adjustments 0.00 0.00 104.64 0.00 0.00 -
Total Income 176.15 41.41 242.63 22.40 2.30 -
EXPENDITURE :            
Raw Materials 70.51 21.55 160.34 20.52 0.00 -
Power and Fuel Cost 20.42 20.55 26.68 8.65 5.15 -
Employee Cost 79.36 72.80 56.97 31.22 25.07 -
Other Manufacturing Expenses 21.98 29.92 36.39 7.52 8.91 -
Selling and Administration Expenses 59.94 43.01 29.48 10.82 13.77 -
Miscellaneous Expenses 148.63 496.28 24.14 14.70 30.80 -
Employee Benefit Expenses 79.36 72.80 56.97 31.22 25.07 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 400.84 684.11 334.00 93.43 83.70 -
Operating Profit -224.69 -642.68 -91.37 -71.04 -81.40 -
Interest 89.42 47.55 68.02 15.80 27.77 -
Gross Profit -314.11 -690.23 -159.39 -86.84 -109.17 -
Depreciation 76.29 108.88 70.35 34.40 28.81 -
Profit Before Tax -390.40 -799.11 -229.74 -121.24 -137.98 -
Current Tax 0.00 0.00 0.00 0.00 0.00 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.00 0.00 0.00 0.00 0.00 -
Reported Net Profit -390.40 -799.11 -229.74 -121.24 -137.98 -
Extraordinary Items -120.99 -157.40 0.13 0.00 -0.02 -
Adjusted Net Profit -269.41 -641.71 -229.87 -121.24 -137.96 -
Adjustment below Net Profit -0.53 0.48 0.28 0.18 137.98 -
P & L Balance brought forward -1,427.22 -628.58 -399.12 -278.05 0.00 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down -1,818.14 -1,427.22 -628.58 -399.12 0.00 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr -973.57 -1,992.80 -58.76 -785.74 -1,460.10 -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 991.88 1,961.88 259.75 5,045.70 4,405.43 -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    29.79%

  • Public Share Holding

    70.21%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 32,937,369 28.77 32,937,369 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,158,830 1.01 1,158,830 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 34,096,199 29.79 34,096,199 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 4,062 0.00 4,062 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,065 0.00 4,065 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 21,390,538 18.69 21,390,538 166
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,510,841 2.19 2,510,841 6
Mutual Funds / UTI 10,371,130 9.06 10,371,130 10
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,836,327 6.85 7,836,327 37
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 42,116,963 36.79 42,116,963 225
2] Non Institution
Bodies Corporate 8,874,019 7.75 8,874,019 931
Clearing Members 0 0.00 0 0
Directors of their Relatives 1,204,072 1.05 1,204,072 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 737,777 0.64 737,777 3,030
Foreign Non Institution Other 9,728,142 8.50 9,728,142 8
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,466,076 3.90 4,466,076 8
Individuals holding nominal share capital up to Rs. 1 lakh 10,697,328 9.35 10,697,328 81,457
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,545,445 2.22 2,545,445 2,087
Sub Total 38,252,859 33.42 38,252,859 87,524
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 114,466,021 100.00 114,466,021 87,760

Company Background

OneSource Specialty Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • OneSource Specialty Pharma Ltd
  • BSE Code : 89433.0
  • ISIN : INE013P01021
  • Incorporation Year

    2007

  • Registered Office

    201 Devarata Sector 17 Vashi
    Navi Mumbai Sanpada, Thane,
    Maharashtra-400703

  • Telephone

    91-22-2789 2924/78929 08076

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Integrated Registry Mgt Ser.Pv
    2nd Floor Kences Tow,
    1 Ramakrishna Street,Usman Road T.Nagar
    Mumbai - Chennai-600017

OneSource Specialty Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
OneSource Speci. 1,847.80 176.14 171.92 1,093.37 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10